ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,159Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 208

$1.48M Total Retail Price of All Prescriptions

Rank: 6 out of 208

1,057 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 1,057 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

2% of this provider’s 6,383 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

60% of this provider’s prescriptions were for brand-name drugs, compared to an average of 51%.

Prescription Price

$162 was the average price of a prescription from this provider, compared to $143 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SYNTHROID 1,488 1,188 1 2
LEVOTHYROXINE SODIUM 428 211 2 1
INSULIN SYRINGE 349 210 3 9
LANTUS 348 227 4 7
PEN NEEDLE 342 238 5 3
METFORMIN HCL ER 337 244 6 13
LANTUS SOLOSTAR 333 256 7 5
METFORMIN HCL 286 179 8 4
HUMALOG 248 166 9 8
NOVOLOG FLEXPEN 236 196 10 11
ALENDRONATE SODIUM 184 146 11 32
NOVOLOG 181 118 12 18
GLIPIZIDE XL 174 148 13 37
JANUVIA 156 118 14 12
ACTOS 138 108 15 22
SIMVASTATIN 137 78 16 6
LEVEMIR FLEXPEN 128 90 17 19
FENOFIBRATE 128 95 17 43
PRAVASTATIN SODIUM 122 98 19 27
ATORVASTATIN CALCIUM 117 88 20 15
ANDROGEL 102 64 S3 21 60
GLIPIZIDE 90 70 22 23
LEVOXYL 84 73 23 16
LEVEMIR 77 57 24 55
ZETIA 74 60 25 30
PIOGLITAZONE HCL 73 57 R 26 53
GLIPIZIDE ER 71 61 27 48
CRESTOR 67 59 28 31
HYDROCHLOROTHIAZIDE 66 66 29 29
FORTEO 66 55 29 139
HUMULIN R 65 18 31 46
LISINOPRIL 63 17 32 14
GLIMEPIRIDE 61 47 33 10
HYDROCORTISONE 58 37 34 40
JANUMET 55 50 35 28
NIASPAN 53 34 36 52
BYDUREON 52 41 37 198
SPIRONOLACTONE 51 0 38 104
LOVAZA 50 25 39 39
VICTOZA 3-PAK 50 19 39 44
EVISTA 50 45 39 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.